J. Henri Bayle
Chief Tech/Sci/R&D Officer presso BELLICUM PHARMACEUTICALS, INC.
Profilo
J.
Henri Bayle is currently working as the Vice President-Research at Bellicum Pharmaceuticals, Inc. He completed his undergraduate degree from the University of Alberta and his doctorate from Princeton University.
Posizioni attive di J. Henri Bayle
| Società | Posizione | Inizio |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2014 |
Formazione di J. Henri Bayle
| University of Alberta | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Borsa valori
- Insiders
- J. Henri Bayle
